quinazolines has been researched along with Sleep Apnea Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parati, G; Pengo, MF; Steier, J | 1 |
| Dempsey, EC; Fagan, KA; Karoor, V; Le, M; Merrick, D; Miller, YE | 1 |
1 review(s) available for quinazolines and Sleep Apnea Syndromes
| Article | Year |
|---|---|
The ANDANTE Project: A Worldwide Individual Data Meta-Analysis of the Effect of Sleep Apnea Treatment on Blood Pressure.
Topics: Blood Pressure; Continuous Positive Airway Pressure; Humans; Quinazolines; Sleep Apnea Syndromes | 2021 |
1 other study(ies) available for quinazolines and Sleep Apnea Syndromes
| Article | Year |
|---|---|
Alveolar hypoxia promotes murine lung tumor growth through a VEGFR-2/EGFR-dependent mechanism.
Topics: Animals; Antioxidants; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Blotting, Western; Butylated Hydroxytoluene; Carcinogens; Cell Proliferation; Cytokines; Epithelial-Mesenchymal Transition; ErbB Receptors; Female; Hypoxia; Immunoenzyme Techniques; Lung Neoplasms; Methylcholanthrene; Mice; Neovascularization, Pathologic; Piperidines; Proto-Oncogene Proteins c-myc; Pulmonary Alveoli; Quinazolines; Sleep Apnea Syndromes; Urethane; Vascular Endothelial Growth Factor Receptor-2 | 2012 |